Yokode, M., Shiokawa, M., Kawakami, H., Kuwada, T., Nishikawa, Y., Muramoto, Y., . . . Seno, H. (2024). Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis. British journal of cancer, 130(9), 1552-1560. https://doi.org/10.1038/s41416-024-02647-1
Chicago Style (17th ed.) CitationYokode, Masataka, et al. "Anti-integrin αvβ6 Autoantibodies Are a Potential Biomarker for Ulcerative Colitis-like Immune Checkpoint Inhibitor-induced Colitis." British Journal of Cancer 130, no. 9 (2024): 1552-1560. https://doi.org/10.1038/s41416-024-02647-1.
MLA (9th ed.) CitationYokode, Masataka, et al. "Anti-integrin αvβ6 Autoantibodies Are a Potential Biomarker for Ulcerative Colitis-like Immune Checkpoint Inhibitor-induced Colitis." British Journal of Cancer, vol. 130, no. 9, 2024, pp. 1552-1560, https://doi.org/10.1038/s41416-024-02647-1.